Levemir FlexPen & NovoRapid FlexPen - Important Safety Information from Novo Nordisk following approval by the IMB
02 February 2009
Please find attached safety information communication from Novo Nordisk regarding the importance of highlighting the differences between these products to patients administering them as part of the treatment of diabetes.
Important Safety Information-Levemir FlexPen and NovoRapid FlexPen